ABSTRACT
A cross-sectional pilot study was conducted on a population of 119 asthmatics who had been recruited from the Emergency Room Department of a major hospital in Ponce, Puerto Rico. The purpose of the study was to determine the frequency of the MM, MS, and SS a-i-antiprotease variants. Also, we analyzed the serum levels of the alpha-1-antiprotease inhibitor, quantified the levels of serine proteases in homes of the asthmatic volunteers, and determined whether environmental levels of proteases, regardless of their sources, had any association with either asthma symptoms or alpha-1-antiprotease inhibitor phenotypes. Our results do not support the role of the alpha-1-antiprotease as a risk factor for asthma in the study population as previously reported. Patients who had visited the ED due to asthma on 3 or more occasions had significantly higher trypsin levels than those who had done so 2 or fewer times. Of those asthmatic patients who had daily symptoms, 40had been exposed to high levels of elastase, and 33.3to trypsin. Similarly, 52.9of the patients with 2 or more hospitalizations a year had been exposed to high elastase levels, and 40.5of asthma patients who had nocturnal asthma more than 3 times a week had been exposed to high levels of elastase.
Subject(s)
Humans , Adult , Middle Aged , Asthma/epidemiology , Asthma/immunology , Peptide Hydrolases/blood , alpha 1-Antitrypsin/analysis , Allergens/immunology , Asthma/blood , Asthma/genetics , Cross-Sectional Studies , Data Interpretation, Statistical , Pancreatic Elastase/immunology , Hospitalization , Phenotype , Pilot Projects , Prevalence , Puerto Rico/epidemiology , Surveys and Questionnaires , Risk Factors , Skin Tests , alpha 1-Antitrypsin/geneticsABSTRACT
Systemic embolism is a major complication of mitral stenosis which is usually related to a presence of left atrial thrombus. Percutaneous balloon mitral valvuloplasty (PBMV) was previously reported to reduce the incidence of this complication. However, the mechanisms of this beneficial procedure was under investigated. The aim of this study was to investigate the changes in coagulation activity, platelet activity and endocardial function in 29 patients with mitral stenosis after successful PBMV. All subjects had good left ventricular systolic function and 48.3% had atrial fibrillation. There was a significant reduction in thrombin-antithrombin complex (TAT) after a successful procedure and the level of thrombomodulin was also significantly higher one month after successful procedure. However, the level of platelet factor 4 (PF4) and beta-thromboglobulin (beta-TG) were increased after this procedure but not achieved the statistical significance. In conclusion, successful PBMV can reduce the prethrombotic state in patients with mitral stenosis. In addition, it may improve endocardial function of the left atrium in those without atrial fibrillation.
Subject(s)
Adult , Antithrombin III , Atrial Function, Left , Female , Hemodynamics , Humans , Male , Mitral Valve Stenosis/blood , Peptide Hydrolases/blood , Thrombomodulin/bloodABSTRACT
A mathematical model has been proposed to study the effect of [TAME] esterase on blood clotting time. Using this model, clotting time was found to decrease by 30% with increasing plasma [TAME] esterase activity in a group of smokers. It is hypothesized that [TAME] esterase through its effect on Hageman factor could affect clotting time. However mechanism of clotting by [TAME] esterase remains to be elucidated. It is concluded that [TAME] esterase is involved in the cascade of reactions leading to blood coagulation and increased [TAME] esterase activity could be an additional risk factor for possible cerebro-vascular accidents in smokers.
Subject(s)
Adult , Aged , Aged, 80 and over , Biomarkers , Blood Coagulation Tests , Cardiovascular Diseases/epidemiology , Comorbidity , Enzyme Activation , Factor XII/metabolism , Humans , Male , Middle Aged , Peptide Hydrolases/blood , Risk Factors , Smoking/adverse effects , Thrombophilia/enzymologyABSTRACT
Se cuantificó la actividad proteolítica de Staphylococcus aureus aislados de infecciones del hombre, aplicando una modificación de la técnica efectuada por otros autores con Pseudomonas aeruginosa. Además del polvo de piel coloreado con Azul Brillante de Remazol utilizado con esta bacteria, se prepararon otros sustratos insolubles, tales como elastina-Rojo Congo, colágeno-Rojo Congo y polvo de ubre-Rojo Congo. Fue posible comprobar mayor actividad proteolítica sobre colágeno que sobre elastina, mientras que con los extractos o polvos tisulares se evidenció más proteólisis con polvo de ubre de vaca (PUH) que con polvo de piel (PPA). Cabe destacar que las cepas procedían de infecciones humanas, incluyendo afecciones no epidérmicas y una de colección ATCC. El método desarrollado constituyó una ventaja con respecto a las técnicas clásicas de bacteriología que detectan cualitativamente la actividad proteolítica